Itoside J



Compound IDCDAMM01641
Common nameItoside J
IUPAC name[2-[6-(benzoyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-5-hydroxyphenyl]methyl 1-hydroxy-5-[[5-hydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methylidene]-6-oxocyclohex-2-ene-1-carboxylate
Molecular formulaC40H42O19

Experimental data

Retention time6.46
Adduct[M+H]+
Actual mz827.232
Theoretical mz827.239
Error8.55
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.1317

Identifiers and class information

Inchi keyVJDJBHKKFHYOAP-PEFXGDRSNA-N
SmilesO=C(OCC1OC(OC2=CC=C(O)C=C2COC(=O)C3(O)C=CCC(=CC4=CC(O)=CC=C4OC5OC(CO)C(O)C(O)C5O)C3=O)C(O)C(O)C1O)C=6C=CC=CC6
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)14
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)23
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)826.76
Computed dipole moment(dipole)6.544
Total solvent accessible surface area (SASA)1177.36
Hydrophobic component of SASA (FOSA)266.046
Hydrophilic component of SASA (FISA)468.794
Pie component of the SASA (PISA)442.519
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2286.39
Number of hydrogen bond donors (donorHB)10
Number of hydrogen bond acceptors (accptHB)25.05
Free energy of solvation of dipole (dip^2/V)0.0187297
Index of cohesive interaction in solids (ACxDN^.5/SA)0.067282
Globularity descriptor (glob)0.712891
Predicted polarizability in cubic angstroms (QPpolrz)74.805
Predicted hexadecane/gas partition coefficient (QPlogPC16)28.904
Predicted octanol/gas partition coefficient (QPlogPoct)54.861
Predicted water/gas partition coefficient (QPlogPw)42.998
Predicted octanol/water partition coefficient (QPlogPo/w)-0.729
Predicted aqueous solubility (QPlogS)-4.377
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.682
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-8.288
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.355
Predicted brain/blood partition coefficient (QPlogBB)-6.972
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.092
Predicted skin permeability, log Kp (QPlogKp)-6.392
PM3 calculated ionization potential (IP(ev))8.866
PM3 calculated electron affinity (EA(eV))0.622
Number of likely metabolic reactions (#metab)12
Prediction of binding to human serum albumin (QPlogKhsa)-1.352
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)325.72
Number of nitrogen and oxygen atoms (#NandO)19
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P15692VEGFAVascular endothelial growth factor AT20761SwissTargetPrediction and SEA
P05230FGF1Acidic fibroblast growth factorT18639SwissTargetPrediction and SEA
P09038FGF2Basic fibroblast growth factorT31621SwissTargetPrediction and SEA
Q9Y251HPSEHeparanaseT47623SwissTargetPrediction
P16109SELPP-selectinT10965SEA
P60568IL2Interleukin-2T61698SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
P14679TYRTyrosinaseT97035SEA
P20916MAGMyelin-associated glycoprotein (by homology)T95286SEA
P09382LGALS1Galectin-1T09544SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T47623DI0020African trypanosomiasis[ICD-11: 1F51]Q9Y251HPSE
T47623DI0310Ocular disease[ICD-11: N.A.]Q9Y251HPSE
T10965DI0088Circulatory system disease[ICD-11: BE2Z]P16109SELP
T10965DI0381Sickle-cell disorder[ICD-11: 3A51]P16109SELP
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T95286DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P20916MAG
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025